An observational study in Jaundice, Neonatal, sponsored by Guangdong Women and Children Hospital. Completed at 1 site in China. Open to participants aged 1 Day to 7 Days, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-12-03.
Sponsored by Guangdong Women and Children Hospital · Observational
Make a neonatal jaundiced nomogram on Chinese jaundice data by joinning the major neonate centers all around China.
This was a multi-centre prospective study. All infants included were born in 8 hospitals in the southern, eastern, northern, western and central regions of mainland China in 2019. A total of 20839 transcutaneous bilirubin(TCB) measurements were performed with 2977 neonates at designated time points. The mean NTL exposure during pregnancy was respectively calculated based on each participant's residential address over the study course. The primary outcome was whether the neonate was diagnosed with hyperbilirubinemia within the first seven days of life. The effect of maternal nocturnal light exposure on neonate jaundice analyzed with lasso regression and random forest machine learning methods.
Term and near term newborns, whos gestational age was more than 35 weeks(≥35)
gestational age more than 35 weeks(≥35) -
Exclusion Criteria:
all kinds of congenital diseases, infants with pathologic jaundice
-
transcutaneous bilirubin(TCB) measurements were performed with 2977 neonates at designated time points. The mean NTL exposure during pregnancy was respectively calculated based on each participant's residential address over the study course.
Hour-specific Transcutaneous Bilirubin Level
make neonatal jaundiced nomogram base on the hour-specific transcutaneous bilirubin data
Time frame: 1 year
whether the neonate was diagnosed with hyperbilirubinemia within the first seven days of life
whether the neonate was diagnosed with hyperbilirubinemia within the first seven days of life
Time frame: 2019
This study is completed, as verified in Nov 2024. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Guangdong Women and Children Hospital